Prosight Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
Prosight Management's INSM Position: Q3 2026 in Review
Prosight Management reduced its Insmed (INSM) stake by 37% in Q3 2026, selling an estimated $16.2M and leaving 238,088 shares worth $27.2M. The position accounts for 5.27% of the portfolio, ranked #6.
Prosight Management first reported a position in INSM in Q1 2023 and has held it in 3 quarters since. The position peaked at $40M in Q2 2026. 704 funds tracked by Wall St. Rank hold INSM as of Q3 2026.
- Prosight Management held 238,088 shares of Insmed worth $27.2M as of Q3 2026.
- Prosight Management sold 137,521 Insmed shares in Q3 2026, an estimated $16.2M.
- Insmed made up 5.27% of Prosight Management's portfolio in Q3 2026, its #6 holding.
- Prosight Management first reported a position in Insmed in Q1 2023 and has held it in 3 quarters since.
- Prosight Management's Insmed position peaked at $40M in Q2 2026.
- 704 funds tracked by Wall St. Rank held Insmed as of Q3 2026.
Based on Prosight Management's 13F filing for Q3 2026, filed 13 Nov 2026.